Navigation Links
ADVENTRX Receives Brand Name Acceptance for ANX-530
Date:3/12/2010

d in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements.  These risks and uncertainties include, but are not limited to: the risk that FDA determines that there is a safety concern related to interchanging ANX-530 with other vinorelbine injectable products; the risk that the FDA's requirements for an ANX-530 NDA to be accepted for review do not justify continued development of ANX-530; ADVENTRX's dependence on the success of ANX-530, and increased uncertainty as to whether ANX-530 will receive regulatory approval or be commercialized successfully; the potential that FDA may not accept a resubmitted ANX-530 NDA for review, or that the bioequivalence data and other information included in the ANX-530 NDA may not adequately support bioequivalence with Navelbine; the potential that changes made in transferring the manufacturing process for ANX-530 may result in a lack of comparability between the commercial product and the material used in clinical trials, and that FDA may require ADVENTRX to perform additional non-clinical or clinical studies; the potential for FDA to impose other requirements to be completed before or after approval of the ANX-530 NDA; the risk that ADVENTRX will have insufficient capital to support its operations during the FDA review of an ANX-530 NDA, should a resubmitted ANX-530 be accepted; the risk that ADVENTRX will pursue development activities at levels or on timelines, or will incur unexpected expenses, that shortens the period through which its operating funds will sustain it; the risk that ADVENTRX will be unable to raise sufficient additional capital to commercialize ANX-530, if an ANX-530 NDA is approved; and other risks and uncertainties more fully describe
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
2. ADVENTRX Announces Management Promotions
3. ADVENTRX Appoints Icahn Representative to Board of Directors
4. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
5. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
6. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
7. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
8. ADVENTRX Pharmaceuticals Announces Closing of Financing
9. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
10. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
11. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of ... present at the 11th National Life Science & Technology Week ... The presentation will be given by Nadav Kidron, Oramed,s President ... during the BioPharma Session. Event: ...
... 21, 2012  PneumRx, Inc. ( www.pneumrx.com ), a ... improvements to the treatment of lung disease, today ... portfolio by acquiring key patents and domain names ... ) As a result of the ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012 2PneumRx, Inc. Acquires Key Assets From Broncus 2
(Date:7/9/2014)... of flatulence and have a reputation for being highly toxic, ... is now being being found to offer potential health benefits ... attacks and dementia. A new compound (AP39), designed and made ... future therapies, by targeting delivery of very small amounts of ... , Scientists in Exeter have already found that the ...
(Date:7/9/2014)... the most important organs in the human body. Its ... properly this is its synthesis function and ... this is its detoxification function. Lack of exercise and ... the liver. The resulting diseased cells can lead to ... failure. According to the German Liver Foundation, over five ...
(Date:7/9/2014)... prescription labels handed out by pharmacists may be ... medication, according to new research by the University ... the Blind)., The study, published recently in the ... on prescription medications dispensed by pharmacies do not ... By simply following recommended guidelines for font size, ...
(Date:7/9/2014)... , , , ... , , , , ... downrange from the firer and approximately 30cm from the bullet... , , ... , , , , ... , , , , , , University of Southampton researchers, with ...
(Date:7/9/2014)... The occurrence of allergic diseases has risen dramatically in ... are less exposed to microorganisms and have fewer infections ... system. , A study by researchers at Sahlgrenska Academy, ... three to examine maturation of the immune system in ... in rural areas of the Vstra Gtaland Region, half ...
Breaking Medicine News(10 mins):Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7
... in the UK has fallen to its lowest levels since ... the National Suicide Prevention Strategy. The report also shows //a ... suicides as well as a decline in the number of ... is a major cause of preventable death in England and ...
... Officer of Health, Dr. Sheela Basrur, not to consume some ... by the Upper Canada Company in Jordan Station. ... Canada Cheese Company products, are being advised to discard them. ... Niagara Gold (washed rind cheese) with a production date label ...
... it has been found that the fries and chicken nuggets served ... the // same and varies from country to country. ,The ... issue of The New England Journal of Medicine found that "the ... in Denmark and Germany, to 10 grams in New York (McDonald's) ...
... Copenhagen said on Saturday, that Denmark's first suspected case of bird ... ,The result of an examination by specialists of a man who ... he was not infected, the spokesman said. A 25 yr old ... in Nykobing on the island of Falster to the hospital in ...
... U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm ... the first device to deliver // insulin as well as ... glucose every five minutes and gives 288 readings per day. ... is an electrode inserted under the skin. This gives continuous ...
... syndrome” is the name given to a condition characterized by ... it remains one of the toughest // conditions for a ... women more than men and is pronounced as a woman ... in patients with type 2 diabetes and individuals taking heart ...
Cached Medicine News:Health News:Fat Content In McDonald’s & KFC's Foods Varies From Country To Countr 2Health News:Fat Content In McDonald’s & KFC's Foods Varies From Country To Countr 3
... PS+ lead series are endocardial ... the best characteristics of polyurethane ... polyurethane outer insulation provides a ... lubricity while the silicone inner ...
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
Unipolar Atrial "J" Lead...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: